Companies › Eli Lilly › Diluted shares

Eli Lilly weighted average diluted shares outstanding, 2008–2025

Eli Lilly reported weighted average diluted shares outstanding of 899.3 million shares for the fiscal year ended Dec. 31, 2025, down 0.5% from 904.1 million shares the year before, according to its Form 10-K.

899.3M shareslatest fiscal year (ended Dec. 31, 2025)
−0.5%change from the year before
1.12B shareshighest year shown (2012)
2008: 1.09B shares ’08 2009: 1.10B shares 2010: 1.11B shares ’10 2011: 1.11B shares 2012: 1.12B shares ’12 2013: 1.08B shares 2014: 1.07B shares ’14 2015: 1.07B shares 2016: 1.06B shares ’16 2017: 1.05B shares 2018: 1.03B shares ’18 2019: 935.7M shares 2020: 912.5M shares ’20 2021: 911.7M shares 2022: 904.6M shares ’22 2023: 903.3M shares 2024: 904.1M shares ’24 2025: 899.3M shares ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly weighted average diluted shares outstanding by fiscal year

Fiscal year endedDiluted sharesChangeFiling
Dec. 31, 2025 899.3M shares −0.5% 10-K (2026) ↗
Dec. 31, 2024 904.1M shares +0.1% 10-K (2026) ↗
Dec. 31, 2023 903.3M shares −0.1% 10-K (2026) ↗
Dec. 31, 2022 904.6M shares −0.8% 10-K (2025) ↗
Dec. 31, 2021 911.7M shares −0.1% 10-K (2024) ↗
Dec. 31, 2020 912.5M shares −2.5% 10-K (2023) ↗
Dec. 31, 2019 935.7M shares −9.5% 10-K (2022) ↗
Dec. 31, 2018 1.03B shares −1.7% 10-K (2021) ↗
Dec. 31, 2017 1.05B shares −0.9% 10-K (2020) ↗
Dec. 31, 2016 1.06B shares −0.4% 10-K (2019) ↗
Dec. 31, 2015 1.07B shares −0.8% 10-K (2018) ↗
Dec. 31, 2014 1.07B shares −1.0% 10-K (2017) ↗
Dec. 31, 2013 1.08B shares −2.9% 10-K (2016) ↗
Dec. 31, 2012 1.12B shares +0.3% 10-K (2015) ↗
Dec. 31, 2011 1.11B shares +0.7% 10-K (2014) ↗
Dec. 31, 2010 1.11B shares +0.7% 10-K (2012) ↗
Dec. 31, 2009 1.10B shares +0.4% 10-K (2012) ↗
Dec. 31, 2008 1.09B shares — 10-K (2011) ↗

Other Eli Lilly financials

RevenueNet incomeDiluted EPSR&D expenseOperating cash flowDividends per shareTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's weighted average diluted shares outstanding in its latest fiscal year?

A Eli Lilly reported weighted average diluted shares outstanding of 899.3 million shares for the fiscal year ended Dec. 31, 2025, down 0.5% from 904.1 million shares the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual weighted average diluted shares outstanding on record here?

A 1.12 billion shares, in the fiscal year ended Dec. 31, 2012, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this weighted average diluted shares outstanding data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Weighted average diluted shares outstanding for the year, as reported. Years before the latest stock split are left out rather than adjusted.

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Weighted average diluted shares outstanding for the year, as reported. Years before the latest stock split are left out rather than adjusted. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.